Bangzhi Zhang

2.2k total citations
61 papers, 1.9k citations indexed

About

Bangzhi Zhang is a scholar working on Molecular Biology, Microbiology and Organic Chemistry. According to data from OpenAlex, Bangzhi Zhang has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 24 papers in Microbiology and 21 papers in Organic Chemistry. Recurrent topics in Bangzhi Zhang's work include Antimicrobial Peptides and Activities (24 papers), Asymmetric Synthesis and Catalysis (12 papers) and Biochemical and Structural Characterization (11 papers). Bangzhi Zhang is often cited by papers focused on Antimicrobial Peptides and Activities (24 papers), Asymmetric Synthesis and Catalysis (12 papers) and Biochemical and Structural Characterization (11 papers). Bangzhi Zhang collaborates with scholars based in China, Hong Kong and Hungary. Bangzhi Zhang's co-authors include Rui Wang, Kairong Wang, Jiexi Yan, Jingjing Song, Wei Zhang, Junqiu Xie, Rui Wang, Linqing Wang, Dongxu Yang and Wen Dang and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Catalysis and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Bangzhi Zhang

60 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bangzhi Zhang China 28 950 746 658 187 135 61 1.9k
Il‐Seon Park South Korea 26 1.1k 1.1× 595 0.8× 109 0.2× 241 1.3× 24 0.2× 57 1.7k
Vincent Lisowski France 21 1.4k 1.4× 359 0.5× 907 1.4× 127 0.7× 31 0.2× 58 2.3k
Jiexi Yan China 17 592 0.6× 578 0.8× 287 0.4× 146 0.8× 5 0.0× 27 1.1k
A. Di Giulio Italy 19 858 0.9× 801 1.1× 186 0.3× 278 1.5× 8 0.1× 62 1.4k
John A. Karas Australia 22 594 0.6× 122 0.2× 249 0.4× 33 0.2× 59 0.4× 52 1.2k
Debra R. Holland United States 14 868 0.9× 154 0.2× 463 0.7× 95 0.5× 14 0.1× 20 1.5k
Xiaojuan Hou China 19 511 0.5× 140 0.2× 195 0.3× 163 0.9× 44 0.3× 55 1.1k
Zhigang Liu China 18 502 0.5× 357 0.5× 319 0.5× 180 1.0× 11 0.1× 45 1.2k
Otto Phanstiel United States 24 1.1k 1.2× 62 0.1× 443 0.7× 114 0.6× 51 0.4× 76 1.7k
William R. Wolter United States 21 502 0.5× 76 0.1× 381 0.6× 70 0.4× 18 0.1× 47 1.5k

Countries citing papers authored by Bangzhi Zhang

Since Specialization
Citations

This map shows the geographic impact of Bangzhi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bangzhi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bangzhi Zhang more than expected).

Fields of papers citing papers by Bangzhi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bangzhi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bangzhi Zhang. The network helps show where Bangzhi Zhang may publish in the future.

Co-authorship network of co-authors of Bangzhi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bangzhi Zhang. A scholar is included among the top collaborators of Bangzhi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bangzhi Zhang. Bangzhi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jingling, et al.. (2025). Parps in immune response: Potential targets for cancer immunotherapy. Biochemical Pharmacology. 234. 116803–116803. 2 indexed citations
2.
Zhang, Jianfeng, et al.. (2024). Beclin-1–Derived Peptide MP1 Attenuates Renal Fibrosis by Inhibiting the Wnt/β-Catenin Pathway. Journal of Pharmacology and Experimental Therapeutics. 389(2). 208–218.
3.
Zhang, Yongliang, Changsheng Chen, Bangzhi Zhang, et al.. (2023). β- l -Rhamnosylation and β- d -Mannosylation Mediated by 4- O -Ester Groups in a Weakly Nucleophilic Environment. Organic Letters. 25(39). 7120–7125. 3 indexed citations
4.
Wang, Dan, Lü Cheng, Jiao Zhang, et al.. (2022). A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis. Acta Pharmaceutica Sinica B. 13(2). 722–738. 18 indexed citations
5.
Wang, Dan, Jieru Li, Jiao Zhang, et al.. (2022). DR7dA, a Novel Antioxidant Peptide Analog, Demonstrates Antifibrotic Activity in Pulmonary Fibrosis In Vivo and In Vitro. Journal of Pharmacology and Experimental Therapeutics. 382(2). 100–112. 6 indexed citations
6.
Wang, Dan, Cheng Lu, Jieru Li, et al.. (2021). Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro. European Journal of Pharmaceutical Sciences. 167. 106009–106009. 12 indexed citations
7.
Yang, Wenle, Dan Wang, Lü Cheng, et al.. (2020). Peptide DR8 suppresses epithelial-to-mesenchymal transition via the TGF-β/MAPK signaling pathway in renal fibrosis. Life Sciences. 261. 118465–118465. 29 indexed citations
8.
Xie, Junqiu, Xiaomin Guo, Tiantian Yan, et al.. (2020). CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA. Biochimie. 176. 1–11. 7 indexed citations
9.
Wang, Dan, Zhibin Yan, Jianfeng Zhang, et al.. (2019). Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress. Toxicology and Applied Pharmacology. 382. 114703–114703. 41 indexed citations
10.
Li, Dan, Linqing Wang, Dongxu Yang, Bangzhi Zhang, & Rui Wang. (2015). Catalytic Desymmetrization of meso-Aziridines with Benzofuran-2(3H)-Ones Employing a Simple In Situ-Generated Magnesium Catalyst. ACS Catalysis. 5(12). 7432–7436. 37 indexed citations
11.
Zhang, Bangzhi, Fengxia Han, Linqing Wang, et al.. (2015). Catalytic Asymmetric Michael Reaction of 5H‐Oxazol‐4‐Ones with α,β‐Unsaturated Acyl Imidazoles. Chemistry - A European Journal. 21(48). 17234–17238. 22 indexed citations
12.
Zhang, Wei, Xiaoli Yang, Jingjing Song, et al.. (2015). Conjugation with Acridines Turns Nuclear Localization Sequence into Highly Active Antimicrobial Peptide. Engineering. 1(4). 500–505. 11 indexed citations
13.
Yang, Dongxu, Linqing Wang, Fengxia Han, et al.. (2013). Direct Site‐Specific and Highly Enantioselective γ‐Functionalization of Linear α,β‐Unsaturated Ketones: Bifunctional Catalytic Strategy. Angewandte Chemie. 125(26). 6871–6874. 52 indexed citations
14.
Yang, Wenle, Bangzhi Zhang, Wei Zhang, Jingjing Song, & Rui Wang. (2013). Advances in the strategies for the development of novel peptide drugs. Scientia Sinica Chimica. 43(8). 941–952. 1 indexed citations
15.
Song, Jingjing, Wei Zhang, Ming Kai, et al.. (2013). Design of an Acid-Activated Antimicrobial Peptide for Tumor Therapy. Molecular Pharmaceutics. 10(8). 2934–2941. 22 indexed citations
16.
Yan, Jiexi, Kairong Wang, Wen Dang, et al.. (2012). Two Hits Are Better than One: Membrane-Active and DNA Binding-Related Double-Action Mechanism of NK-18, a Novel Antimicrobial Peptide Derived from Mammalian NK-Lysin. Antimicrobial Agents and Chemotherapy. 57(1). 220–228. 108 indexed citations
17.
Zhang, Bangzhi, Kairong Wang, Jiexi Yan, et al.. (2010). In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides. Peptides. 31(4). 568–573. 7 indexed citations
18.
19.
20.
Li, Min, Wei Liu, Yanfang Zhu, et al.. (2006). Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer. Acta Oncologica. 45(8). 1115–1119. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Il‐Seon Park Breakdown of academic impact, for papers by Vincent Lisowski Breakdown of academic impact, for papers by Jiexi Yan Breakdown of academic impact, for papers by A. Di Giulio Breakdown of academic impact, for papers by John A. Karas Breakdown of academic impact, for papers by Debra R. Holland Breakdown of academic impact, for papers by Xiaojuan Hou Breakdown of academic impact, for papers by Zhigang Liu Breakdown of academic impact, for papers by Otto Phanstiel Breakdown of academic impact, for papers by William R. Wolter
Rankless by CCL
2026